CRISPR Therapeutics
CRISPR Therapeutics is a biotechnology company advancing gene-editing medicines across multiple disease areas. The Statistical Programming Contractor will provide technical statistical programming support for clinical development and regulatory submissions. The role supports R&D clinical programs and contributes to cross-functional initiatives on a contract basis.
Headquarters
Boston, Massachusetts, United States
Company Size
201-500 employees
Founded
2013
CRISPR Therapeutics is a gene-editing company pioneering the development of transformative medicines using CRISPR/Cas9 technology to treat serious diseases. The company has a broad pipeline spanning hemoglobinopathies, immuno-oncology, autoimmune diseases, in vivo editing, and regenerative medicine, including CASGEVY™, the first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics operates across multiple clinical and preclinical programs in collaboration with partners such as Vertex Pharmaceuticals.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CRISPR Therapeutics.
CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story
2 days ago
Associate Director, Statistical Programming
Corcept Therapeutics
Sr. Manager/AD, Statistical Programmer
Beam Therapeutics
Associate Director, Statistical Programming
Revolution Medicines
Associate Director/Director, Biostatistical Programming
Relay Therapeutics
Director, Statistical Programming
Seaport Therapeutics
Senior Manager, Statistical Programming
Dyne Therapeutics